PAP
Persistent Asset Partners Portfolio holdings
AUM
$208M
1-Year Est. Return
95.31%
This Fund
S&P 500
1 Year Est. Return
+95.31%
AUM
$208M
AUM Growth
+$70M
(+51%)
Holding
392
Top Buys
| 1 | +$8.43M | |
| 2 | +$5.15M | |
| 3 | +$4.26M | |
| 4 |
SNDK
Sandisk
SNDK
|
+$3.61M |
| 5 |
Johnson & Johnson
JNJ
|
+$3.5M |
Top Sells
| 1 | +$4.82M | |
| 2 | +$3.15M | |
| 3 | +$2.87M | |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$2.84M |
| 5 |
Labcorp
LH
|
+$2.58M |
Sector Composition
| 1 | Healthcare | 56.04% |
| 2 | Technology | 14.52% |
| 3 | Financials | 12.06% |
| 4 | Communication Services | 4.8% |
| 5 | Energy | 3.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
HCA Healthcare
HCA
$109B
| – | – |
-2,353
|
|
||
377
Warrior Met Coal
HCC
$4.56B
| – | – |
-3,716
|
|
||
378
iShares Bitcoin Trust
IBIT
$60.9B
| – | – |
-44,200
|
|
||
379
Interactive Brokers
IBKR
$36.4B
| – | – |
0
|
|
||
380
iShares 7-10 Year Treasury Bond ETF
IEF
$49.7B
| – | – |
-50,000
|
|
||
381
iShares Morningstar Value ETF
ILCV
$1.23B
| – | – |
0
|
|
||
382
Incyte
INCY
$19.5B
| – | – |
0
|
|
||
383
Janux Therapeutics
JANX
$962M
| – | – |
0
|
|
||
384
Kodiak Sciences
KOD
$2.78B
| – | – |
0
|
|
||
385
Kratos Defense & Security Solutions
KTOS
$13.3B
| – | – |
0
|
|
||
386
Legend Biotech
LEGN
$3.92B
| – | – |
0
|
|
||
|
387
Labcorp
LH
$22.2B
| – | – |
-8,994
|
|
||
388
Lyell Immunopharma
LYEL
$560M
| – | – |
0
|
|
||
389
McKesson
MCK
$106B
| – | – |
-772
|
|
||
|
DFTX
390
Definium Therapeutics
DFTX
$2.26B
| – | – |
-24,282
|
|
||
|
MREO
391
Mereo BioPharma
MREO
$53.7M
| – | – |
0
|
|